XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (4,074,362) $ (3,232,155)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 1,056,131 102,851
Common stock and stock option based compensation for employees and board of directors 1,717,462 1,289,381
Acquisition contingent consideration fair value adjustment (2,822,600)
Common stock issuance for additional asset acquisition consideration 197,498  
Issuance of common stock to vendors as compensation 147,895
Amortization of right-to-use-assets 190,052  
Loss on conversion of convertible notes 279,730
Changes in operating assets and liabilities:    
Accounts receivable (373,055) (661,491)
Pre-offering costs 470,136
Deferred costs/contract assets 482,133 3,181
Prepaid expenses and other current assets (130,336) (359,921)
Other assets 30,100 (64,000)
Accounts payable (439,737) (238,736)
Accrued liabilities (132,876) (63,090)
Accrued bonuses 125,451 (33,852)
Deferred revenue/contract liabilities (2,123,680) 311
Lease liabilities (196,435)
Net cash used in operating activities (6,494,254) (2,359,760)
Cash flow from investing activities:    
Purchases of equipment (119,588) (50,080)
Acquisitions, net of cash acquired (2,478,756) (300,000)
Sale (purchase) of investments 2,738 (247,430)
Net cash used in investing activities (2,595,606) (597,510)
Cash flows from financing activities:    
Proceeds from initial public offering, net 11,821,364
Proceeds from securities purchase agreement, net 13,578,400
Proceeds from exercise of stock options 44,916 613,620
Net cash provided by financing activities 44,916 26,013,384
Net change in cash, cash equivalents and restricted cash (9,044,944) 23,056,114
Cash, cash equivalents and restricted cash, beginning of period 18,249,666 1,771,929
Cash, cash equivalents and restricted cash, end of period 9,204,722 24,828,043
Non-cash Investing and Financing activities:    
Common stock issued for acquisitions 2,846,144 1,050,000
Common stock issued for satisfaction of prior year acquisition lability 734,036
Common stock issued for purchase of intangible asset - technology 326,436
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment 318,571
Extinguishment of note receivable for satisfaction of contingent liability 250,000
Contingent acquisition consideration liability 6,139,000
Lease liabilities arising from right-of-use assets 1,155,769
Common stock issued and escrowed for acquisition 4,000,000
Issuance of common stock for satisfaction of legacy acquisition liability 790,000
Conversion of convertible promissory notes into common stock 1,606,176
Issuance of warrants in connection with initial public offering 522,360
Issuance of warrants in connection with securities purchase agreement $ 8,797,546